Note: [] Address for correspondence: Lina Carvalho Anatomia
Patológica Hospitais da Universidade de Coimbra IPATIMUP, Universidade
do Porto Portugal
Abstract: A great effort has been undertaken done to determine prognostic and
therapeutic markers to enhancing diagnosis and survival. These targets have
been focused by the recent technological developments and knowledge in
genetics, molecular biology and informatics. As tumorgenesis is associated with
chromosomic alterations, these can be validated by measurable differences in
DNA content analysis either by flow on static cytometry. The second method is
more appreciated by pathologists and frequently applied to solid tumors. A
total number of 120 lung carcinomas has been classified according to the WHO
classification is 42 adenocarcinomas, 38 squamous cell carcinomas, 12
carcinoids, 9 adenosquamous carcinomas, 6 bronchioloalveolar carcinomas, 8
large cell neuroendocrine carcinomas, 3 pleomorphic carcinomas and 2 small cell
combined carcinomas. They have been submitted to static cytometry for DNA
quantification. The study was made by application of Feulgen´s stain to
touch smears of each tumor and then validated by the digital equipment CAS 200.
The DNA content analysis distinguished two levels: namely diploid and
non-diploid tumors. A correlation between non-detectable lymphnode metastases
and small size (<3cm) of squamous cell carcinomas was seen with diploid
tumors and improved prognosis. In the group of adenocarcinomas, the large
variability of DNA content hinders the utility of this variable to define the
progression of the disease. Carcinoids and the other types of neuroendocrine
carcinomas could be distinguished by diploidy and aneuploidy. In this way, DNA
image analysis is useful for a detailed morphological evaluation, and can be
used to estimate the prognosis. The use of DNA content to defining the
prognosis of lung cancer patients has to be considered to be biased by the
applied method and the variability of DNA content in different histological
groups of lung carcinoma. In adenocarcinomas, it has been shown that a higher
DNA index correlates with a higher frequency of brain metastasis. In squamous
cell carcinomas, aneuploidy correlates with shorter survival.